Correlation between Genotypic and Phenotypic Testing for Resistance to Rifampin in Mycobacterium tuberculosis Clinical Isolates in Haiti: Investigation of Cases with Discrepant Susceptibility Results

Use of Luminex MagPlex Magnetic Microspheres for High-Throughput Spoligotyping of Mycobacterium tuberculosis Isolates in Port-au-Prince, Haiti

(2013) O. Ocheretina et al.   JOURNAL OF CLINICAL MICROBIOLOGY

False-positive rifampicin resistance on Xpert® MTB/RIF: case report and clinical implications [Technical note]

(2012) A. Van Rie et al.   INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE

Performance of Tuberculosis Drug Susceptibility Testing in U.S. Laboratories from 1994 to 2008

(2012) P. K. Angra et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Molecular Characterization of Multidrug- and Extensively Drug-Resistant Mycobacterium tuberculosis Strains in Jiangxi, China

(2012) X. Yuan et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Evaluation of the Xpert MTB/RIF Assay for the Diagnosis of Pulmonary Tuberculosis in a High HIV Prevalence Setting

(2011) Grant Theron et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Isolation of Mycobacterium tuberculosis Strains with a Silent Mutation inrpoBLeading to Potential Misassignment of Resistance Category

(2011) María Alonso et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Silent Mutation in rpoB Detected from Clinical Samples with Rifampin-Susceptible Mycobacterium tuberculosis

(2011) R. Moure et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Evaluation of the Cepheid Xpert MTB/RIF Assay for Direct Detection of Mycobacterium tuberculosis Complex in Respiratory Specimens

(2011) E. M. Marlowe et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Feasibility, diagnostic accuracy, and effectiveness of decentralised use of the Xpert MTB/RIF test for diagnosis of tuberculosis and multidrug resistance: a multicentre implementation study

(2011) Catharina C Boehme et al.   LANCET

Whole-genome sequencing of rifampicin-resistant Mycobacterium tuberculosis strains identifies compensatory mutations in RNA polymerase genes

(2011) Iñaki Comas et al.   NATURE GENETICS

Screening for HIV-Associated Tuberculosis and Rifampicin Resistance before Antiretroviral Therapy Using the Xpert MTB/RIF Assay: A Prospective Study

(2011) Stephen D. Lawn et al.   PLOS MEDICINE

Comparison of Xpert MTB/RIF with Other Nucleic Acid Technologies for Diagnosing Pulmonary Tuberculosis in a High HIV Prevalence Setting: A Prospective Study

(2011) Lesley E. Scott et al.   PLOS MEDICINE

New Susceptibility Breakpoints for First-Line Antituberculosis Drugs Based on Antimicrobial Pharmacokinetic/Pharmacodynamic Science and Population Pharmacokinetic Variability

(2010) T. Gumbo   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Rapid Molecular Detection of Tuberculosis and Rifampin Resistance

(2010) Catharina C. Boehme et al.   NEW ENGLAND JOURNAL OF MEDICINE

A Long Journey from Minimum Inhibitory Concentration Testing to Clinically Predictive Breakpoints: Deterministic and Probabilistic Approaches in Deriving Breakpoints

(2009) A. Dalhoff et al.   INFECTION

Performance Assessment of the GenoType MTBDRplus Test and DNA Sequencing in Detection of Multidrug-Resistant Mycobacterium tuberculosis

(2009) W.-L. Huang et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Mycobacterium tuberculosis Strains with Highly Discordant Rifampin Susceptibility Test Results

(2009) A. Van Deun et al.   JOURNAL OF CLINICAL MICROBIOLOGY

GenoType MTBDR assays for the diagnosis of multidrug-resistant tuberculosis: a meta-analysis

(2008) D. I. Ling et al.   EUROPEAN RESPIRATORY JOURNAL